Sa1244 BASELINE CHARACTERISTICS OF EOSINOPHILIC ESOPHAGITIS DO NOT PREDICT HISTOLOGIC RESPONSE TO DUPILUMAB: A RETROSPECTIVE, REAL-WORLD STUDY von Sia, Twan, Miller, Amanda, Bacchus, Leeon, Young, Jennie, Narayan, Aditya P., Solecki, Rachel, Fu, Jerry, Zheng, Michelle, Shami, Saad, Roby, Alyssa, Telukunta, Tanvi, McDonald, Paige, Matmatte, Amina Sara, Mallik, Shibani, Love, Kathleen, Liu, Stanley, Khuda, Raisa, Jiang, Yuting, Headen, Madison, Leung, John

Volltext

Clinical and histologic remission achieved with upadacitinib in a patient with refractory eosinophilic gastritis and duodenitis von Fu, Jerry, Sia, Twan, Solecki, Rachel, Mallik, Shibani, Khuda, Raisa, Headen, Madison, Bacchus, Leeon, Zheng, Michelle, Telukunta, Tanvi, Shami, Saad, Liu, Stanley, Sureshbabu, Sripad, Love, Kathleen, Roby, Alyssa, McDonald, Paige, Jiang, Yuting, Narayanan, Dharaneswari Hari, Cunningham, Evan, Matmatte, Amina Sara, Tan, Puay Eng, Leung, John

Volltext

Dupilumab improves clinical and histologic features of eosinophilic esophagitis prior to 12 weeks of treatment von Sia, Twan, Miller, Amanda, Bacchus, Leeon, Young, Jennie, Narayan, Aditya P., Solecki, Rachel, Fu, Jerry, Jiang, Yuting, Khuda, Raisa, Liu, Stanley, Love, Kathleen, Mallik, Shibani, Matmatte, Amina Sara, McDonald, Paige, Telukunta, Tanvi, Roby, Alyssa, Shami, Saad, Zheng, Michelle, Headen, Madison, Leung, John

Volltext